Charles River Labs, Thursday chart focus keeps shares under review
Published on 06/25/2026 at 17:56 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
By Daniel Hoffmann, Chart & Technicals desk. Reviewed prior to publication on 2026-06-25, 15:56.
Charles River Labs (US1598641074) trades on the NYSE, and Thursday's setup keeps the stock in a chart-led frame. The broader market was mixed at midday, with the Nasdaq 100 slightly lower and the S&P 500 also down, according to Barchart's June 25 market overview Barchart market overview for June 25.
The tape around healthcare
Healthcare stocks are moving inside a market that is not giving one clear direction. FT Markets listed Bayer, Vale and Micron among the day's larger cross-asset headlines, while broad US index performance stayed mixed on Thursday FT Markets equity headlines.
For Charles River Labs, that kind of tape matters because the shares trade as part of a sector that often reacts to risk appetite, earnings revision trends and defensive rotation. The current backdrop leaves the stock tied more closely to market structure than to a single overnight catalyst.
Chart levels matter
Thursday's focus sits on the chart rather than on a fresh corporate event. With the Nasdaq 100 down 0.20% and the S&P 500 down 0.18% in Barchart's midday update, relative performance is the main point to watch for Charles River Labs shares.
That makes the next session useful for checking whether the stock holds its recent range against a weaker technology-led tape. The move sits inside a broader US session that investors can read as cautious rather than directional.
All news and analysis on Charles River Labs shares
Track company updates, market reactions and the latest research around the shares.
The business behind it
Charles River Labs provides nonclinical and discovery research services for drug developers, with work centered on preclinical testing, laboratory support and related research tools. The company says it serves the pharmaceutical, biotechnology, agrochemical, government and academic sectors through a broad services platform.
Where the stock trades today
Charles River Labs shares traded at 0.00 USD as of 2026-06-25 15:56 UTC.
Charles River Labs at a glance
- Company: Charles River Laboratories International, Inc.
- ISIN: US1598641074
- Ticker: CRL
- Trading venue: NYSE
- Price (as of 2026-06-25, 15:56): 0.00 USD
- Sector / industry: Health Care / Life Sciences Tools and Services
- Index membership: S&P 500
This article was produced with AI assistance and editorially reviewed. Price and company figures without guarantee; prices and dates may change at short notice. No investment advice, no buy or sell recommendation. Stock-market transactions carry risks up to and including total loss.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
